Cargando…
Assessment of Treatment Effects and Long-term Benefits in Immune Checkpoint Inhibitor Trials Using the Flexible Parametric Cure Model: A Systematic Review
IMPORTANCE: Compared with standard cytotoxic therapies, randomized immune checkpoint inhibitor (ICI) phase 3 trials reveal delayed benefits in terms of patient survival and/or long-term response. Such outcomes generally violate the assumption of proportional hazards, and the classical Cox proportion...
Autores principales: | Filleron, Thomas, Bachelier, Marine, Mazieres, Julien, Pérol, Maurice, Meyer, Nicolas, Martin, Elodie, Mathevet, Fanny, Dauxois, Jean-Yves, Porcher, Raphael, Delord, Jean-Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693223/ https://www.ncbi.nlm.nih.gov/pubmed/34932105 http://dx.doi.org/10.1001/jamanetworkopen.2021.39573 |
Ejemplares similares
-
Addressing the issue of bias in observational studies: Using instrumental variables and a quasi-randomization trial in an ESME research project
por: Ezzalfani, Monia, et al.
Publicado: (2021) -
Variable selection in a flexible parametric mixture cure model with interval‐censored data
por: Scolas, Sylvie, et al.
Publicado: (2015) -
Estimating time-to-onset of adverse drug reactions from spontaneous reporting databases
por: Leroy, Fanny, et al.
Publicado: (2014) -
Multidisciplinary Approach of Immune Checkpoint Inhibitor–Related Pneumonitis: A Key to Address Knowledge and Management Gaps
por: Pérol, Maurice
Publicado: (2020) -
Estimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival models
por: Andersson, Therese ML, et al.
Publicado: (2011)